Higher temperatures linked to severity of allergic conjunctivitis

Article

Temperatures measured by a newly developed non-contact ocular surface thermographer (OST) can be used to evaluate the efficacy of topical anti-allergic agents because of the significant correlation of the conjunctival surface temperature and the severity of conjunctival allergic reaction, according to recently published data.

Temperatures measured by a newly developed non-contact ocular surface thermographer (OST) can be used to evaluate the efficacy of topical anti-allergic agents because of the significant correlation of the conjunctival surface temperature and the severity of conjunctival allergic reaction, according to the results of a study published in Ophthalmic Research.

Researchers from Ehime University School of Medicine included 13 asymptomatic patients with seasonal allergic conjunctivitis due to cedar pollen. They instilled a 0.025% levocabastine ophthalmic suspension in one eye and artificial tears in the other eye, in a masked fashion 10 minutes prior to a conjunctival allergen challenge (CAC). A drop of cedar pollen solution was then given into the conjunctival sac to induce an allergic reaction.

The surface temperature of the inferior bulbar conjunctiva was measured before and 30 minutes after CAC with a newly developed non-contact ocular surface thermographer (OST) Slit-lamp biomicroscopy was also used to measure the degree of conjunctival injection and chemosis. A questionnaire was used to evaluate symptoms.

After CAC, temperatures increased by 0.67 °C in the artificial tear eyes, and only by 0.21 °C in the levocabastine eyes (P P P

To access the abstract of this study, click here.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.